Challenges in the diagnosis and treatment of mucormycosis.

The armamentarium of antifungals is slightly enriched by the addition of two newer azoles (posaconazole and isavuconazole) to liposomal amphotericin B, which remains the drug of choice for the initial antIfungal treatment, according to the recently published guidelines by ECIL-6.